AfricaRegulatory
African Pharmaceutical Regulatory Intelligence
🇿🇦
Brolucizumab in South Africa
1 product registered with SAHPRA — 1 active
| Brand / Product | Reg. No. | Holder | Status | Expires |
|---|---|---|---|---|
| VSIQQ | 54/15.4/0489 | Novartis South Africa (Pty) Ltd | active | 8 Jun 2031 |
Brolucizumab — SAHPRA Registration Details
SAHPRA (South Africa) has 1 registered product containing Brolucizumab, of which 1 is currently active. Data is sourced directly from the official SAHPRA drug register and refreshed daily.
Track Brolucizumab registration expiry dates, monitor competitor approvals, and receive alerts when registration status changes. Create a free account to set up portfolio monitoring.